Aclaris Therapeutics Reports Second Quarter 2017 Financial Results

Go back to Aclaris Therapeutics Reports Second Quarter 2017 Financial Results
(NASDAQ: ACRS) Delayed: 4.92 +0.13 (2.71%)
Previous Close $4.79    52 Week High $33.88 
Open $4.77    52 Week Low $14.12 
Day High $4.97    P/E N/A 
Day Low $4.76    EPS $0.00 
Volume 801,830